Luxembourg Institute of Health (LIH) Market Research Report

Background

The Luxembourg Institute of Health (LIH) is a public biomedical research organization established in 1988 as the Centre de Recherche Public de la Santé (CRP-Santé). In January 2015, it merged with the Integrated BioBank of Luxembourg (IBBL) to form the current entity. Governed under the Ministry of Health and the Ministry of Research, LIH is dedicated to advancing biomedical sciences with a focus on precision health. Its mission is to translate scientific excellence into meaningful benefits for patients, aiming to become a leading reference in Europe for the application of research in healthcare.

Key Strategic Focus

LIH's strategic focus encompasses:

Core Objectives: To investigate disease mechanisms, develop new diagnostics, innovative therapies, and effective tools for personalized medicine.

Areas of Specialization: Oncology, Infection and Immunity, Population Health.

Key Technologies Utilized: Advanced motion capture and activity monitoring techniques for assessing human movement and physical activity.

Primary Markets Targeted: Luxembourg and Europe, with a commitment to improving public health through research and collaboration.

Financials and Funding

LIH operates with an annual budget of approximately €40 million. About 60% of its funding is provided directly by the Government of Luxembourg, while the remaining 40% is sourced from competitive research funding (national research fund, EU funding) and contract research for public administrations or the pharmaceutical and biotech industry.

Pipeline Development

LIH is involved in various research projects, including:

Con-Vince Study: Investigating the spread dynamics of COVID-19 in Luxembourg, focusing on asymptomatic cases.

Predi-Covid Study: Examining risk factors and biomarkers associated with the severity and long-term health consequences of COVID-19.

PERFORM Project: A PhD project funded by the FNR Industrial Fellowships grant, investigating dietary fiber–microbiome interactions through metabolic modeling.

Technological Platform and Innovation

LIH employs several innovative platforms, including:

Vocal Biomarker Platform: An AI-driven solution transforming voice into a monitoring tool for clinical trials, enabling remote patient participation and real-time monitoring.

Advanced Motion Capture and Activity Monitoring: Techniques used to assess human movement and physical activity in lab-based or real-life environments.

Leadership Team

LIH's leadership includes:

Dr. Guy Fagherazzi: Director of the Department of Precision Health.

Ms. Joséphine Ayroles: HR Partner.

Ms. Juliette Pertuy: Communication Manager.

Mr. Arnaud D’Agostini: Head of Marketing and Communication.

Ms. Marion Chezel: Contact Person.

Ms. Hélène De Franco: PhD Student in Nutrition, Microbiome, and Immunity.

Competitor Profile

Market Insights and Dynamics

The biomedical research sector in Luxembourg is characterized by a strong emphasis on precision health and personalized medicine. Key players include the Luxembourg Institute of Science and Technology (LIST) and the Luxembourg Institute of Socio-Economic Research (LISER). The market is supported by substantial government funding and a collaborative research environment.

Competitor Analysis

Luxembourg Institute of Science and Technology (LIST): Focuses on applied research and development in various scientific fields, including materials science, environment, and IT.

Luxembourg Institute of Socio-Economic Research (LISER): Specializes in social and economic policy research, addressing topics like poverty, inequality, and health.

Strategic Collaborations and Partnerships

LIH has engaged in several strategic collaborations:

Catalpa Ventures Partnership: A five-year partnership launched in February 2024 to drive innovation in digital health by bridging scientific research and venture capital.

Medical & Bio Decision (MBD) Collaboration: Established a joint research laboratory in Luxembourg in January 2021 to advance precision oncology using MBD's 3D cell culture platform.